Lawsuit: St. Jude waited years before recalling faulty defibrillators

A collection of third-party insurance payers has filed a class-action lawsuit seeking $9.9 million from St. Jude Medical and parent company Abbott Laboratories, claiming St. Jude knew about a battery defect in its cardiac defibrillators nearly five years before issuing a recall.

Filed Sept. 18 in Chicago by law firms DiCello Levitt & Casey and...

Lawsuit: St. Jude waited years before recalling faulty defibrillators Continue reading…

FDA warns of death, liver injury risks from Intercept’s drug

(Reuters) - The U.S. Food and Drug Administration (FDA) warned on Thursday that Intercept Pharmaceuticals Inc’s drug Ocaliva was being incorrectly dosed in some patients with a rare liver disease, increasing the risk of liver injury and death.

The U.S. drugmaker’s shares fell 10.4 percent to $87.90 in afternoon trading following the news.

FDA warns of death, liver injury risks from Intercept’s drug Continue reading…

Investors seek class action status in lawsuit over St. Jude implantable defib batteries

Abbott (NYSE:ABT) is facing an investor suit from an Alaskan union-benefits fund over allegations that St. Jude Medical, which it closed its acquisition of in January, failed to notify regulators about defective lithium batteries in its implantable defibrillators.

In the lawsuit, plaintiffs allege that St. Jude was informed of the battery defect “as early as...

Investors seek class action status in lawsuit over St. Jude implantable defib batteries Continue reading…

Lawsuit seeks damages for faulty batteries in St. Jude defibrillators

An Alaska union-benefits fund is suing Abbott Laboratories over allegations that Minnesota-based medical device company St. Jude Medical, which is owned by Abbott, failed to warn the public and regulators for years that thousands of its implantable defibrillators contained defective lithium batteries.

The federal lawsuit, filed in northern Illinois late Monday, alleges that St. Jude...

Lawsuit seeks damages for faulty batteries in St. Jude defibrillators Continue reading…

Smiths Medical confirms drug pump vulnerable to cyberhacking

Smiths Medical, the Plymouth-based maker of hospital infusion pumps, confirmed earlier this month cybersecurity vulnerabilities in its Medfusion 4000 drug pumps, which are used in pediatric cases worldwide.

The company said Monday that it has received no reports of computer hackers exploiting the ­vulnerabilities.

Read More

Equifax two top technology executives leave company ‘effective immediately’

WASHINGTON (Reuters) - Equifax said on Friday that it made changes in its top management as part of its review of a massive data breach, with two technology and security executives leaving the company “effective immediately.”

The credit-monitoring company announced the changes in a press release that gave its most detailed public response to date...

Equifax two top technology executives leave company ‘effective immediately’ Continue reading…

Child psychiatric disorders tied to in utero antidepressant exposure

 Antidepressant use during pregnancy is tied to an increased risk of psychiatric illnesses, especially mood disorders, in children, according to a new study.

The overall risk is low, though. Only about 3 percent of the nearly 905,383 children in the study were diagnosed with a psychiatric disorder by age 16.

But compared to the children of...

Child psychiatric disorders tied to in utero antidepressant exposure Continue reading…